| 1 |
32914380 | MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway. | 2021 Aug |
2 |
| 2 |
33574948 | Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment. | 2021 Mar |
1 |
| 3 |
33578797 | SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells. | 2021 Feb 10 |
1 |
| 4 |
33653494 | Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy. | 2021 Jan 1 |
3 |
| 5 |
33662352 | Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation. | 2021 May 5 |
4 |
| 6 |
33963708 | [Synergistic effect of polysaccharide from Trichoderma pseudokoningii and oxaliplatin on colorectal cancer cells in vitro]. | 2021 Apr 20 |
1 |
| 7 |
33982772 | LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. | 2021 Jul |
4 |
| 8 |
33986248 | A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. | 2021 May 13 |
1 |
| 9 |
34017210 | MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway. | 2021 |
2 |
| 10 |
34017681 | MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer. | 2021 |
1 |
| 11 |
34052504 | The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK. | 2021 Jul 23 |
4 |
| 12 |
34193174 | SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer. | 2021 Jun 30 |
1 |
| 13 |
34477047 | RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway. | 2021 Dec |
1 |
| 14 |
34750753 | Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells. | 2021 Dec |
1 |
| 15 |
31972222 | A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer. | 2020 Mar 15 |
1 |
| 16 |
32209726 | Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. | 2020 Mar 25 |
2 |
| 17 |
32331534 | The AKT/GSK3-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1. | 2020 Sep 1 |
2 |
| 18 |
32818544 | GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway. | 2020 Nov 1 |
3 |
| 19 |
30468657 | Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway. | 2019 Jan 1 |
1 |
| 20 |
30672917 | Cyanidin inhibits EMT induced by oxaliplatin via targeting the PDK1-PI3K/Akt signaling pathway. | 2019 Feb 20 |
1 |
| 21 |
30926638 | RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer. | 2019 May |
2 |
| 22 |
31423282 | Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical model. | 2019 Aug |
2 |
| 23 |
31497229 | PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway. | 2019 |
2 |
| 24 |
29115606 | DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. | 2018 Jan |
2 |
| 25 |
29378575 | Effects of Omegaven®, EPA, DHA and oxaliplatin on oesophageal adenocarcinoma cell lines growth, cytokine and cell signal biomarkers expression. | 2018 Jan 30 |
1 |
| 26 |
29497313 | Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell. | 2018 |
5 |
| 27 |
29721050 | Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. | 2018 |
1 |
| 28 |
29737584 | Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression. | 2018 Aug |
1 |
| 29 |
29844803 | Sphingosine kinase 1 overexpression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma. | 2018 Jun |
1 |
| 30 |
28463955 | Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway. | 2017 May 2 |
3 |
| 31 |
28621236 | Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial. | 2017 Jun |
1 |
| 32 |
26733168 | Reactive oxygen species mediate oxaliplatin-induced epithelial-mesenchymal transition and invasive potential in colon cancer. | 2016 Jun |
1 |
| 33 |
27091625 | Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway. | 2016 Apr 19 |
1 |
| 34 |
27245421 | Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein. | 2016 Sep |
1 |
| 35 |
27633443 | Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer. | 2016 Dec |
2 |
| 36 |
25444914 | Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. | 2015 Feb 1 |
2 |
| 37 |
25777765 | Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells. | 2015 Jul |
1 |
| 38 |
23279642 | Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma. | 2013 Mar |
1 |
| 39 |
21245990 | LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway. | 2011 Jan 14 |
3 |
| 40 |
21718595 | Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells. | 2011 Jul |
1 |
| 41 |
22811824 | Insulin caused drug resistance to oxaliplatin in colon cancer cell line HT29. | 2011 Mar |
2 |
| 42 |
19128511 | Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells. | 2009 Jan 8 |
1 |
| 43 |
19240026 | Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. | 2009 Apr 17 |
1 |
| 44 |
18767116 | Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells. | 2008 Nov 1 |
3 |
| 45 |
18790786 | Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells. | 2008 Sep |
2 |
| 46 |
16891475 | Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases. | 2006 Jul |
1 |